Deltec Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-20,000
| Closed | -$68K | – | 207 |
|
|
2018
Q3 | $68K | Hold |
20,000
| – | – | 0.01% | 171 |
|
|
2018
Q2 | $75K | Hold |
20,000
| – | – | 0.02% | 166 |
|
|
2018
Q1 | $82K | Hold |
20,000
| – | – | 0.02% | 175 |
|
|
2017
Q4 | $93K | Hold |
20,000
| – | – | 0.02% | 166 |
|
|
2017
Q3 | $142K | Hold |
20,000
| – | – | 0.03% | 159 |
|
|
2017
Q2 | $145K | Hold |
20,000
| – | – | 0.03% | 152 |
|
|
2017
Q1 | $123K | Hold |
20,000
| – | – | 0.03% | 158 |
|
|
2016
Q4 | $117K | Hold |
20,000
| – | – | 0.03% | 150 |
|
|
2016
Q3 | $106K | Hold |
20,000
| – | – | 0.02% | 148 |
|
|
2016
Q2 | $132K | Sell |
20,000
-20,000
| -50% | -$132K | 0.03% | 135 |
|
|
2016
Q1 | $187K | Buy |
40,000
+20,000
| +100% | +$93.5K | 0.05% | 128 |
|
|
2015
Q4 | $101K | Buy |
+20,000
| New | +$101K | 0.03% | 140 |
|